SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-034050
Filing Date
2018-05-29
Accepted
2018-05-29 21:26:16
Documents
2
Period of Report
2018-05-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1574
2 POA DOCUMENT poa.txt EX-24.3_792850 3080
  Complete submission text file 0001209191-18-034050.txt   6137
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Issuer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERSARTIS, INC. 4200 BOHANNON DR., SUITE 250 MENLO PARK CA 94025
Business Address
Ward Shane (Reporting) CIK: 0001638380 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36783 | Film No.: 18866345